Joaquim Bellmunt, Medical oncologist at Harvard Medical School, shared a post on X about a paper he co-authored with colleagues published in Nature Communications:
“Our paper ‘Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent cohorts’ is out today at Nature Communications. Data of 707 advanced bladder cancer pts treated with anti-PD-1/anti-PD-L1 to build highly accurate predictive models.”
Authors: Lilian Marie Boll, Sergio Vázquez Montes de Oca, Marta Camarena, Robert Castelo, Joaquim Bellmunt, Júlia Perera-Bel, Mar Albà.
More posts featuring Joaquim Bellmunt.
